New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among ...

The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side effects. Historically, ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

The United States Digestive Enzyme Supplements Market is projected to grow from US$ 0.45 billion in 2025 to US$ 0.68 billion by 2033, at a CAGR of 5.37%. This growth is driven by rising awareness of ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of reach for many, newly approved tablet forms are expected to significantly ...

Eli Lilly (LLY) has built up its inventory for its experimental weight loss pill, orforglipron, as the Indiana-based pharma giant awaits a potential FDA approval for the oral GLP-1 drug over the ...

For decades, researchers have been looking for an effective weight-loss pill. But the recent success of glucagon-like peptide-1 (GLP-1) weight-loss injections has sparked new hope — especially for ...

COPENHAGEN, Denmark — Novo Nordisk sued Hims and Hers Health on Monday over alleged patent infringement after the U.S. telehealth firm launched, then canceled, a $49 copy of Novo's weight-loss pill ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy — two days after it announced the new drug and one day after the Food and Drug Administration ...

Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug and one day after the Food and Drug ...